共 116 条
- [1] Bolden JE(2006)Anticancer activities of histone deacetylase inhibitors Nat Rev Drug Discov 5 769-784
- [2] Peart MJ(2002)Histone-deacetylase inhibitors: novel drugs for the treatment of cancer Nat Rev Drug Discov 1 287-299
- [3] Johnstone RW(2001)The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species Proc Natl Acad Sci USA 98 10833-10838
- [4] Johnstone RW(2007)Analysis of the apoptotic and therapeutic activities of histone deacetylase inhibitors by using a mouse model of B cell lymphoma Proc Natl Acad Sci USA 104 8071-8076
- [5] Ruefli AA(2008)Characterisation of the novel apoptotic and therapeutic activities of the histone deacetylase inhibitor romidepsin Mol Cancer Ther 7 1066-1079
- [6] Ausserlechner MJ(2009)The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy Blood 114 380-393
- [7] Bernhard D(2001)Up-regulation of p21(WAF1/CIP1) by histone deacetylase inhibitors reduces their cytotoxicity Mol Pharmacol 60 828-837
- [8] Sutton VR(2007)Histone deacetylase inhibitors: signalling towards p21cip1/waf1 Int J Biochem Cell Biol 39 1367-1374
- [9] Tainton KM(1995)p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene Genes Dev 9 650-662
- [10] Kofler R(1998)The murine gene p27Kip1 is haplo-insufficient for tumour suppression Nature 396 177-180